Oncolytic Virus Market

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasnt until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Oncolytic Virus Market contains market size and forecasts of Oncolytic Virus in global, including the following market information:

• Global Oncolytic Virus Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Oncolytic Virus Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Oncolytic Virus companies in 2021 (%)

The global Oncolytic Virus market was valued at 17 million in 2021 and is projected to reach US$ 27 million by 2028, at a CAGR of 6.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Imlygic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Oncolytic Virus include Amgen and Shanghai Sunway Biotech etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Oncolytic Virus manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oncolytic Virus Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oncolytic Virus Market Segment Percentages, by Type, 2021 (%)

• Imlygic
• Oncorine
• Others

Global Oncolytic Virus Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oncolytic Virus Market Segment Percentages, by Application, 2021 (%)

• Melanoma
• Other Cancers

Global Oncolytic Virus Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Oncolytic Virus Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa
• Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Oncolytic Virus revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Oncolytic Virus revenues share in global market, 2021 (%)
• Key companies Oncolytic Virus sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Oncolytic Virus sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen
• Shanghai Sunway Biotech